Jiangsu Kanion Pharmaceutical Co.,Ltd.

XSSC:600557 Stock Report

Market Cap: CN¥8.1b

Jiangsu Kanion PharmaceuticalLtd Future Growth

Future criteria checks 2/6

Jiangsu Kanion PharmaceuticalLtd is forecast to grow earnings and revenue by 19% and 16% per annum respectively. EPS is expected to grow by 19.5% per annum. Return on equity is forecast to be 11.4% in 3 years.

Key information

19.0%

Earnings growth rate

19.5%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate16.0%
Future return on equity11.4%
Analyst coverage

Good

Last updated05 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600557 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,3268109258478
12/31/20255,6316939039888
12/31/20244,5535442325283
9/30/20244,481544507875N/A
6/30/20244,574526530975N/A
3/31/20244,8745439241,301N/A
12/31/20234,8685377441,041N/A
9/30/20234,7215038391,157N/A
6/30/20234,8074998581,078N/A
3/31/20234,625466652856N/A
12/31/20224,351434785996N/A
9/30/20224,190395667837N/A
6/30/20223,977372714869N/A
3/31/20223,8653478431,014N/A
12/31/20213,649321737908N/A
9/30/20213,344282620767N/A
6/30/20213,254278442634N/A
3/31/20213,075267342517N/A
12/31/20203,032263511701N/A
9/30/20203,471321414780N/A
6/30/20203,850409521944N/A
3/31/20204,305479443939N/A
12/31/20194,566507436926N/A
9/30/20194,435480549975N/A
6/30/20194,242455453834N/A
3/31/20194,008428289613N/A
12/31/20183,825414337664N/A
9/30/20183,619381276534N/A
6/30/20183,457384N/A453N/A
3/31/20183,401382N/A569N/A
12/31/20173,275374N/A383N/A
9/30/20173,136382N/A339N/A
6/30/20173,161374N/A253N/A
3/31/20173,071378N/A171N/A
12/31/20163,000374N/A299N/A
9/30/20162,960367N/A467N/A
6/30/20162,896363N/A588N/A
3/31/20162,861363N/A515N/A
12/31/20152,820362N/A515N/A
9/30/20152,815358N/A352N/A
6/30/20152,755349N/A336N/A
3/31/20152,631329N/A370N/A
12/31/20142,563320N/A312N/A
9/30/20142,477324N/A372N/A
6/30/20142,418323N/A408N/A
3/31/20142,338311N/A418N/A
12/31/20132,230297N/A388N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600557's forecast earnings growth (19% per year) is above the savings rate (2.8%).

Earnings vs Market: 600557's earnings (19% per year) are forecast to grow slower than the CN market (26.1% per year).

High Growth Earnings: 600557's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600557's revenue (16% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 600557's revenue (16% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600557's Return on Equity is forecast to be low in 3 years time (11.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y